Medigen Vaccine Biologics Corp. said Sunday it will soon apply to the Food and Drug Administration in Taiwan and other countries for new drug approval for its enterovirus 71 (EV71) vaccine, as it has successfully completed its Phase III clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Taiwanese writer Peng Ko dies aged 100
07/02/2025 10:57 PM - Business
Taiwan to help industries facing exchange rate fluctuations
07/02/2025 10:35 PM - Politics
2 more KMT lawmakers to face recall votes on Aug. 23
07/02/2025 10:32 PM - Society
Worker dies after falling unconscious at Taoyuan CPC Corp. facility
07/02/2025 09:58 PM - Politics
Taiwan, U.S. face 'bumps' in ongoing tariff talks: VP
07/02/2025 09:58 PM